Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin Vs Erythromycin in PPROM Management
NCT07394725Phase 1Completed
- Sponsor
- DHQ Teaching Hospital Sahiwal
- Start
- Apr 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of azithromycin in preterm premature rupture of membranes (pPROM) (2 arms), sponsored by DHQ Teaching Hospital Sahiwal. Primary endpoints: Latency period at 7 days, Incidence of chorioamnionitis at 7 days and 5 more. Started Apr 2024; status: completed.
02
Drugs
azithromycin
03
Conditions
preterm premature rupture of membranes (pPROM)
Beyond the preview
Go deeper on NCT07394725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07394725.